Goldman Sachs Said Buy This Stock a Year Ago. Now It's Lost 61%
24/7 Wall Street reports that Goldman Sachs cut its price target by more than half while maintaining a buy rating, and the stock subsequently lost 61%. The item describes the outcome as an example of how a correct diagnosis can still lead to substantial portfolio losses.
Why it matters — FMC watchers may note the item’s cautionary discussion of the stock, though the excerpt does not identify the company as FMC.